The healthcare stock winning from COVID-19

13 March 2020
| By Laura Dew |
image
image
expand image

A New Zealand healthcare firm is one of the few stocks to see a material increase in its share price in light of COVID-19.

Fisher & Paykel Healthcare, which was based in New Zealand but listed on the ASX in 2001, had seen its share price rise 9.8% year to date to 12 March. This is a sharp contrast to the stock market performance of the ASX 200 which had fallen 19.7% over the same period.

The firm produced respiratory equipment such as humidifiers, as well as disposable medical equipment such as chambers and breathing circuits, used to deliver gases received during ventilation.

Its flagship product was a respiratory humidifier for patients who were being ventilated in intensive care.

Founded in 1934 in Auckland, its share price has risen by 325% in the past five years compared to returns of 22.9% by the ASX 200, according to FE Analytics.

Stephen Wood, manager of the $5.6 million Eiger Australian Small Companies fund, said: “Fisher & Paykel produces respiratory equipment and consumables which can only be used once. The boost to the business will be more than shortlived and it could give the business a big step-up.

“Healthcare firms will do well and see increased activity, they are defensive stocks so are less reliant on consumer spending.”

It is also known for producing kitchen appliances such as washing machines, ovens and fridges under a separate company Fisher & Paykel Appliances.

Share price of Fisher & Paykel Healthcare year to date versus ASX 200

Read more about:

AUTHOR

 

Recommended for you

 

MARKET INSIGHTS

sub-bg sidebar subscription

Never miss the latest news and developments in wealth management industry

Ralph

How did the licensee not check this - they should be held to task over it. Obviously they are not making sure their sta...

12 hours 33 minutes ago
JOHN GILLIES

Faking exams and falsifying results..... Too stupid to comment on JG...

13 hours ago
PETER JOHNSTON- AIOFP

Must agree to disagree with you on this one Keith, with the Banks/Institutions largely out of advice now is the time to ...

13 hours 42 minutes ago

AustralianSuper and Australian Retirement Trust have posted the financial results for the 2022–23 financial year for their combined 5.3 million members....

9 months 2 weeks ago

A $34 billion fund has come out on top with a 13.3 per cent return in the last 12 months, beating out mega funds like Australian Retirement Trust and Aware Super. ...

9 months 1 week ago

The verdict in the class action case against AMP Financial Planning has been delivered in the Federal Court by Justice Moshinsky....

9 months 3 weeks ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND